Xi Luo

1.4k total citations
31 papers, 733 citations indexed

About

Xi Luo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xi Luo has authored 31 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in Xi Luo's work include Endoplasmic Reticulum Stress and Disease (4 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Xi Luo is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Xi Luo collaborates with scholars based in China, United States and Italy. Xi Luo's co-authors include Joel Gelernter, Huiping Zhang, Henry R. Kranzler, Fengxiao Zhang, Dan Huang, Meng Du, Kai Huang, Kun Huang, Xiaoxiang Mao and Yan Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Xi Luo

30 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Luo China 13 399 222 156 123 111 31 733
Paresh Prajapati United States 19 629 1.6× 245 1.1× 248 1.6× 41 0.3× 152 1.4× 29 899
Carolina Sellitto Italy 7 388 1.0× 195 0.9× 376 2.4× 199 1.6× 125 1.1× 8 976
Ju Gao China 14 335 0.8× 60 0.3× 141 0.9× 148 1.2× 66 0.6× 67 797
Shaomin Yang China 18 316 0.8× 139 0.6× 60 0.4× 81 0.7× 115 1.0× 56 816
Caroline Schönfeld Germany 11 214 0.5× 100 0.5× 85 0.5× 57 0.5× 107 1.0× 14 584
Cheryl de Vallière Switzerland 15 470 1.2× 96 0.4× 136 0.9× 118 1.0× 165 1.5× 28 786
Qiang Jiang China 14 367 0.9× 206 0.9× 59 0.4× 107 0.9× 77 0.7× 37 685
Aneesha Radhakrishnan India 14 285 0.7× 111 0.5× 128 0.8× 87 0.7× 38 0.3× 20 576
Pankaj Ahluwalia United States 15 284 0.7× 129 0.6× 78 0.5× 116 0.9× 108 1.0× 35 697

Countries citing papers authored by Xi Luo

Since Specialization
Citations

This map shows the geographic impact of Xi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Luo more than expected).

Fields of papers citing papers by Xi Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Luo. The network helps show where Xi Luo may publish in the future.

Co-authorship network of co-authors of Xi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Luo. A scholar is included among the top collaborators of Xi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Luo. Xi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Heng, Miaomiao Xie, Xi Luo, et al.. (2024). DOCK8 gene mutation alters cell subsets, BCR signaling, and cell metabolism in B cells. Cell Death and Disease. 15(11). 871–871. 5 indexed citations
2.
Zhang, Jing, Fei Sun, Qianqian Xu, et al.. (2024). Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes. Molecular Medicine. 30(1). 23–23. 3 indexed citations
3.
Li, Dong, Weiguo Chen, Xi Luo, et al.. (2024). Constructing bone organoids based on endochondral ossification model via endogenous enzyme-induced mineralization. Chemical Engineering Journal. 502. 157930–157930. 8 indexed citations
4.
Luo, Xi, Pin Wu, Yulan Ma, et al.. (2024). STIM1 promotes cervical cancer progression through autophagy activation via TFEB nuclear translocation. Cellular Signalling. 125. 111500–111500.
5.
Zhang, Jing, Longmin Chen, Qianqian Xu, et al.. (2023). Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation. Cell Death and Disease. 14(11). 737–737. 2 indexed citations
6.
Mao, Xiaoxiang, Yi Zhong, Ru Chen, et al.. (2023). Kruppel-like factor 14 ameliorated obesity and related metabolic disorders by promoting adipose tissue browning. American Journal of Physiology-Endocrinology and Metabolism. 325(6). E744–E754. 1 indexed citations
7.
Sun, Fei, Faxi Wang, He Zhu, et al.. (2022). SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis. Cell Death and Disease. 13(2). 181–181. 14 indexed citations
8.
Xie, Hao, Yuhan Wang, Xin Liu, et al.. (2022). SUMOylation of ERp44 enhances Ero1α ER retention contributing to the pathogenesis of obesity and insulin resistance. Metabolism. 139. 155351–155351. 14 indexed citations
9.
Zheng, Zhe, Yue Li, Siyuan Fan, et al.. (2021). WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1. Cell Death and Disease. 12(3). 228–228. 10 indexed citations
10.
Du, Meng, Xiaojing Wang, Yuan Lin, et al.. (2020). Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology. 73(6). 1333–1346. 29 indexed citations
11.
Li, Na, Xi Luo, Ping Yang, et al.. (2020). SUMOylation of Pdia3 exacerbates proinsulin misfolding and ER stress in pancreatic beta cells. Journal of Molecular Medicine. 98(12). 1795–1807. 10 indexed citations
12.
13.
Li, Na, Panpan Jiang, Anwei Chen, et al.. (2020). CX3CR1 positively regulates BCR signaling coupled with cell metabolism via negatively controlling actin remodeling. Cellular and Molecular Life Sciences. 77(21). 4379–4395. 9 indexed citations
14.
Zheng, Ying, Xi Luo, Zailong Qin, & Zhiguang Zhou. (2020). Identification of Differentially Expressed lncRNAs in a CpG ODN‐Activated Macrophage. Journal of Immunology Research. 2020(1). 1407654–1407654. 2 indexed citations
15.
Du, Meng, Xiaojing Wang, Xiaoxiang Mao, et al.. (2019). Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. Theranostics. 9(16). 4688–4703. 33 indexed citations
16.
Du, Meng, Yuan Lin, Xin Tan, et al.. (2017). The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation. Nature Communications. 8(1). 2049–2049. 213 indexed citations
17.
Liu, Yang, Kun Huang, Xiangrao Li, et al.. (2013). Identification of Poly(ADP-Ribose) Polymerase-1 as a Cell Cycle Regulator through Modulating Sp1 Mediated Transcription in Human Hepatoma Cells. PLoS ONE. 8(12). e82872–e82872. 26 indexed citations
18.
Zhang, Fengxiao, Yan Wang, Lin Wang, et al.. (2013). Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription. Journal of Biological Chemistry. 288(16). 11348–11357. 57 indexed citations
19.
Han, Meifang, Wei Yan, Yufeng Huang, et al.. (2008). The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP Alpha. The Journal of Biochemistry. 144(1). 51–62. 25 indexed citations
20.
Zhang, Huiping, et al.. (2007). The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Molecular Psychiatry. 13(5). 531–543. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paresh Prajapati Breakdown of academic impact, for papers by Carolina Sellitto Breakdown of academic impact, for papers by Ju Gao Breakdown of academic impact, for papers by Shaomin Yang Breakdown of academic impact, for papers by Caroline Schönfeld Breakdown of academic impact, for papers by Cheryl de Vallière Breakdown of academic impact, for papers by Qiang Jiang Breakdown of academic impact, for papers by Aneesha Radhakrishnan Breakdown of academic impact, for papers by Pankaj Ahluwalia
Rankless by CCL
2026